700 Participants NeededMy employer runs this trial

Anticoagulation Management for Cancer

(ACE-HIGH Trial)

MC
JS
Overseen ByJoseph Shaw, MD, MSc, FRCPC
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Ottawa Hospital Research Institute
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to help find how safe current practices are when managing blood thinners in people with cancer who are having surgery or medical procedures. Investigators will also measure how often bleeding or clotting problems happen in this setting. The goal is to use this information to improve future care and reduce these risks for patients. This study will determine whether contemporary practices can be safely applied to cancer patients, and also evaluate the blood thinner level left over in patient's body at the time of surgery.

Who Is on the Research Team?

JS

Joseph Shaw, MD, MSc, FRCPC

Principal Investigator

Ottawa Hospital Research Institute

Are You a Good Fit for This Trial?

This trial is for adults with active or recently treated cancer who are taking certain blood thinners (like Apixaban, Rivaroxaban, Edoxaban, or Dabigatran) and need to temporarily stop these medications before having a planned surgery or procedure related to their cancer.

Inclusion Criteria

I need to stop my blood thinner medication before the procedure.
I have active or recently treated cancer, or am awaiting a biopsy for suspected cancer.
I am taking a blood thinner like apixaban, rivaroxaban, edoxaban, or dabigatran.
See 2 more

What Are the Treatments Tested in This Trial?

Interventions

  • standardized perioperative anticoagulation management Guideline

Trial Overview

The study is testing the safety of current guidelines for managing blood thinners around the time of surgery in people with cancer. It tracks how often bleeding or clotting problems happen when following these practices.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: study interventionExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Ottawa Hospital Research Institute

Lead Sponsor

Trials
585
Recruited
3,283,000+